651 Epidemiology of Serogroup B Meningococcal Outbreaks and Interim Guidelines for the Use of an Unlicensed Serogroup B Vaccine Under a CDC-Sponsored IND for the Control of Outbreaks in Organizational Settings

Documenti analoghi

• University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013–2018
  di: Soeters, Heidi M., et al.
  Pubblicazione: (2019)
• First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak
  di: McNamara, Lucy A., et al.
  Pubblicazione: (2015)
• Adoption of Serogroup B Meningococcal Vaccine Recommendations
  di: Kempe, Allison, et al.
  Pubblicazione: (2018)
• Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College — Rhode Island, 2015
  di: Soeters, Heidi M., et al.
  Pubblicazione: (2015)
• Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control
  di: Balmer, Paul, et al.
  Pubblicazione: (2018)